NS
ALNY icon

NBC Securities’s Alnylam Pharmaceuticals ALNY Stock Holding History

NBC Securities’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-10
Closed -$3.31K – 2424
2026
Q1 		$3.31K Buy
10
+2
+25% +$681 ﹤0.01% 2215
2025
Q4 		$3.18K Sell
8
-4
-33% -$1.77K ﹤0.01% 2323
2025
Q3 		$5.47K Hold
12
– – ﹤0.01% 2178
2025
Q2 		$3K Buy
+12
New +$3.32K ﹤0.01% 2195
2024
Q1 		– Sell
-16
Closed -$3K – 2180
2023
Q4 		$3K Hold
16
– – ﹤0.01% 1935
2023
Q3 		$2K Buy
+16
New +$3.05K ﹤0.01% 1983

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

NBC Securities's ALNY Position: Q2 2026 in Review

NBC Securities sold out of Alnylam Pharmaceuticals (ALNY) in Q2 2026, closing a stake of 10 shares — an estimated $3.31K sold.

NBC Securities first reported a position in ALNY in Q3 2023 and held it in 6 quarters. The position peaked at $5.47K in Q3 2025. 790 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.

  • NBC Securities reported no remaining Alnylam Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • NBC Securities sold 10 Alnylam Pharmaceuticals shares in Q2 2026, an estimated $3.31K.
  • NBC Securities first reported a position in Alnylam Pharmaceuticals in Q3 2023 and held it in 6 quarters.
  • NBC Securities's Alnylam Pharmaceuticals position peaked at $5.47K in Q3 2025.
  • 790 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.

Based on NBC Securities's 13F filing for Q2 2026, filed 21 Jul 2026.